$2.93
-$0.10
(-3.30%)
Quote as of 4:00 PM EST on 02/10/12
AVANIR PHARMACEUTICALS
NASDAQ:AVNR
Related Resources
AVNR
vs. S&P 500
|
$2.93
-$0.10
(-3.30%)
|
|
| Today's Open | $2.99 |
|---|---|
| Previous Close | $3.03 |
| Daily Range | $2.92 - $3.03 |
| 52-Week Range | $1.77 - $4.80 |
| Market Cap | $371.99M |
| P/E Ratio | -5.83 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,033,102 |
| Average Daily Volume | 1,678,153 |
| Current FY EPS | -$0.45 |
AVNR Information
| Description |
|---|
| A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Is Avanir Pharmaceuticals the Perfect Stock?
2/8/2012 by DailyFinance
These 5 Companies Have Dominated 2012
1/20/2012 by DailyFinance
The Worst Health-Care Stocks of 2011
12/31/2011 by DailyFinance
You've Got 4 Days Left to Do This
12/27/2011 by DailyFinance
A No-Good, Really Bad, Awful Year for This Pharmaceutical Company
12/23/2011 by DailyFinance
12/15/2011 by DailyFinance
3 Biotechs Making Big Moves on Big News
12/13/2011 by DailyFinance
7 Reasons to Worry About Next Week
12/9/2011 by DailyFinance
Whoa! What Just Happened to My Stock?
11/29/2011 by DailyFinance
11/28/2011 by DailyFinance
